Federal contractor · public award history

INTRAVACC B.V.

UEIRY3NEWMNZA63CAGEH2MN6SAM ActiveBILTHOVEN

Parent: INTRAVACC B.V. RY3NEWMNZA63

Awards we know about
2
Typical size
$8.31M
Middle of their public awards
Dollars on those awards
$16.62M

Most of their awards we can see fall roughly between $7.46M and $9.16M.

SAM.gov registration

Public extract 2026-07-05

Status
Active
Purpose of registration
All awards (Z2)
Registration expires
Jan 19, 2027
Activation date
Jan 19, 2026
Primary NAICS (SAM)
541714

Other NAICS on file

Business types (SAM)

Foreign Owned20For Profit Organization2X

Entity website

Registration fields from the official SAM.gov public entity extract (monthly bulk). Not a substitute for live SAM checks.

From official USAspending contract records — not a capability rating, past-performance score, or recommendation to team or bid.

Awarding agencies

  • Department of Health and Human Services (2)

Industries & product codes

Award history

  • Department of Health and Human Services$6.61M
    Jun 25, 2025PIID 75N93022C00058NAICS 541715PSC AN12AWARDUSAspending ↗

    DEVELOPMENT OF AN INTRANASAL VACCINE AGAINST GONORRHEA BASED ON OUTER MEMBRANE VESICLES COMBINED WITH SUSTAINED-RELEASE MICROSPHERES CONTAINING RECOMBINANT HUMAN INTERLEUKIN-12.

  • Department of Health and Human Services$10.01M
    Apr 16, 2025PIID 75N93020C00037NAICS 541715PSC AJ12AWARDUSAspending ↗

    TO DEVELOP AN INTRAMUSCULAR INACTIVATED WHOLE VIRUS VACCINE FROM EARLY PRODUCT SELECTION THROUGH A PHASE I CLINICAL TRIAL TO INDUCE PROTECTION AGAINST EV D68 INDUCED AFM.

Intelligence only — not legal advice, not a past-performance evaluation, and not a recommendation to team or bid. Verify on USAspending and SAM.gov.

Related open government contracts

Industry 541715

Open SAM.gov notices in industries where this company has public awards — not exclusive work for this firm.